Cell No. : Cell Name
RCB2817 : A529L update : 2024/04/04 |
||||
Comment | Human cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/. | |||
Comment from the depositor | ||||
Terms and conditions | In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Jpn J Clin Oncol 2001;31:311-317) designated by the DEPOSITOR is required. | |||
Remarks | ||||
Order Form | Order Form(C-0005.pdf) MTA(C-0007.pdf) MTA(C-0007p.pdf) | |||
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp). | ||||
Basic information | Depositor | Yasumoto, Kosei | ||
Originator | Yasumoto, Kosei | |||
Year of deposit | 2008 | |||
Animal | _human < Mammals | |||
Genus | Homo | |||
Species | sapiens | |||
Race | Japanese | |||
Gender | Male | |||
Age at sampling | 72 years | |||
Tissue | lung | |||
Disease name | adenosquamous cell carcinoma | |||
Metastatic ability | Yes | |||
Classification | cancer | |||
Year of origin | 1996 | |||
Lifespan | infinite | |||
Morphology | epithelial-like | |||
Cellosaurus(Expasy) | CVCL_8655 | |||
Medium | Medium List | |||
Culture type | Adherent cells | |||
Culture medium | RPMI1640 + 10% FBS | |||
Antibiotics | Free | |||
Passage method | 0.25% Trypsin + (0.02% EDTA or 0.04% EDTA) | |||
Culture information | Passage ratio | 1 : 4 split | ||
SC frequency | Subculture : once/2 weeks, Medium Renewal : 2 times/week | |||
Temperature | 37 ℃ | |||
CO2 concentration | 5 % | |||
Freeze medium | Medium + 10% DMSO | |||
Freezing method | Slow freezing | |||
Mycoplasma/Acholeplasma | (-) | |||
Isozyme | LD, NP | |||
STR(human) | OK | |||
Images | ||||
|
|
|||
Reference information | Reference | 6 | ||
User's Publication | 2 | |||
Reference |
8991 Manabu Yasuda, Takeshi Hanagiri, Yoshiki Shigematsu, Takamitsu Onitsuka, Kouji Kuroda, Tetsurou Baba, Makiko Mizukami, Yoshinobu Ichiki, Hidetaka Uramoto, Mitsuhiro Takenoyama, Kosei Yasumoto Identification of a Tumour Associated Antigen in Lung Cancer Patients With Asbestos Exposure Anticancer Res 2010 30 (7), 2631-9 PubMed ID: 20682992 |
8995 Takashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada, Yoshiki Shigematsu, Tetsuro Baba, Yoshika Nagata, Makiko Mizukami, Masakazu Sugaya, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto Cytokine Production of Lung Cancer Cell Lines: Correlation Between Their Production and the Inflammatory/Immunological Responses Both in Vivo and in Vitro Cancer Sci 2007 98 (7), 1048-54 PubMed ID: 17511773 DOI: 10.1111/j.1349-7006.2007.00507.x |
9004 Makiko Mizukami, Takeshi Hanagiri, Manabu Yasuda, Koji Kuroda, Yoshiki Shigematsu, Tetsuro Baba, Takashi Fukuyama, Yoshika Nagata, Tetsuya So, Yoshinobu Ichiki, Masakazu Sugaya, Tomoko So, Mitsuhiro Takenoyama, Kenji Sugio, Kosei Yasumoto Antitumor Effect of Antibody Against a SEREX-defined Antigen (UOEH-LC-1) on Lung Cancer Xenotransplanted Into Severe Combined Immunodeficiency Mice Cancer Res 2007 67 (17), 8351-7 PubMed ID: 17804751 DOI: 10.1158/0008-5472.CAN-06-3889 |
7413 Mizukami M, Hanagiri T, Baba T, Fukuyama T, Nagata Y, So T, Ichiki Y, Sugaya M, Yasuda M, Takenoyama M, Sugio K, Yasumoto K. Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course. Cancer Sci 2005 96(12):882-8 PubMed ID: 16367908 DOI: 10.1111/j.1349-7006.2005.00119.x |
3626 So T, Takenoyama M, Sugaya M, Yasuda M, Eifuku R, Yoshimatsu T, Hanagiri T, Oyama T, Kodate M, Osaki T, Yasumoto K. Generation of autologous tumor-specific T cell clones from a patient with adenosquamous carcinoma of the lung. Jpn J Clin Oncol 2001 31(7):311-7 PubMed ID: 11518743 DOI: 10.1093/jjco/hye062 |
3636 Takenoyama M, Yoshino I, Eifuku R, So T, Imahayashi S, Sugaya M, Yasuda M, Inoue M, Ichiyoshi Y, Osaki T, Nagashima A, Nomoto K, Yasumoto K. Successful induction of tumor-specific cytotoxic T lymphocytes from patients with non-small cell lung cancer using CD80-transfected autologous tumor cells. Jpn J Cancer Res 2001 92(3):309-15 PubMed ID: 11267941 DOI: 10.1111/j.1349-7006.2001.tb01096.x |
User's Publication |
22524 Kasai F, Fukushima M, Miyagi Y, Nakamura Y. Genetic diversity among the present Japanese population: evidence from genotyping of human cell lines established in Japan Hum Cell 2024 37(4):944-950 PubMed ID: 38639832 DOI: 10.1007/s13577-024-01055-0 |
11040 Koh Furugaki, Marie Mochizuki, Mirei Kohno, Sei Shu, Naoki Harada, Yasushi Yoshimura Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion BMC Cancer 2019 19(1):301 PubMed ID: 30943926 DOI: 10.1186/s12885-019-5527-2 |